Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Approvals Analysis: Drug-Coated Balloon, Valve Tech Are July Highlights

Executive Summary

July was a relatively light month for novel-device approvals by US FDA, but year-to-date volumes remain strong. Spotlighted devices include approval of a new drug-coated balloon and heart valve devices. Here's a roundup from Medtech Insight's Approval Tracker.

You may also be interested in...



Edwards’ Resilia Surgical Valve Proves Durability in COMMENCE Study

Four-year data from the COMMENCE trial of surgical valves made of Resilia bovine pericardial tissue showed no early or late structural valve deterioration or valve thrombosis.

'Sutureless' Surgical Aortic Valves Gain Medicare Bonus Payments

Edwards LifeScience’s Intuity Elite and LivaNova’s Perceval sutureless valves were granted a $6,000 new technology hospital inpatient add-on payment for fiscal 2018.

Philips Grows Image-Guided Intervention Focus With Spectranetics Buy

In its second acquisition this month and fourth this year, Philips is buying US device maker Spectranetics Corp. for about $2bn to add laser atherectomy catheters to its vascular imaging line-up.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

MT105276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel